1 The oral sedative potencies of cannabis herb, crude ethanolic and petroleum-ether fractions, were assayed against A'-trans-tetrahydrocannabinol (THC) administered orally to mice, by measuring spontaneous motor activity over 30 min periods, at selected times, up to 6 h. 2 The THC contents of the extracts were determined chemically by gas-liquid chromatography analysis and the B/C ratio (biological activity divided by chemical activity) calculated for each. The B/C values for cannabis herb, which contained THC but no CBD, was 4.47 and for ethanolic and petroleum-ether extracts, 5.26 and 4.39, respectively. 3 The sedative potency expressed as SDA^, the dose required to give 50% effect over 6 h, was 1.06 (0.98 to 1.15) mg/kg for THC; 4.72 (4.22 to 5.27) mg/kg for cannabidiol and 1.26 (1.22 to 1.80) mg/kg for chlorpromazine. 4 An infusion of cannabis herb made with boiling water was shown to have sedative activity of very low potency. 5 When the cannabinoids were completely extracted from a sample of herb with petroleum-ether the aqueous and ethanolic extracts of the marc had some sedative activity; but the 70% ethanoiic fraction had none. 6 The sedative activity of THC, cannabis herb and a water soluble fraction is blocked by aspirin, a cyclo-oxygenase inhibitor, and restored by prostaglandin E2 (PGE2). 7 The sedative effect of chlorpromazine is not blocked by aspirin.
Introduction
Oral cannabis preparations and A'-trans-tetrahydrocannabinol (THC) have a sedative and tranquillising effect in man accompanied by diminished anxiety at doses much lower than those which produce psychoactivity (Hollister, Richards & Gillespie, 1968; Noyes, Brunk, Baram & Canter, 1976; Graham, Davies, Seaton & Weatherstone, 1976) . Extracts of cannabis and THC also have a sedative effect in mice, measured as a decrease in spontaneous motor activity (Carlini, Karniol, Renault & Schuster, 1974) . I have used Tuck No. 1 strain albino female mice in these experiments and measured sedation as a reduction in spontaneous motor activity. The method is based on that of several other workers (Siegel, 1946; Riley & Spinks, 1958; Harris, 1964; Somers, 1960; Svensson & Thieme, 1969) . I have used THC as a standard and I have chosen the oral route since previous work has shown that THC and cannabis are active at very much lower doses after oral administration than when given intraperitoneally (Fairbaim & Pickens, 1979; 1981) . I have attempted to discover whether the 0007-1188/81/040649-08 $01.00 sedative action of 'whole' herb and extracts is related to their THC contents measured by gas-liquid chromatography (g.l.c.) analysis, by the method of Fairbairn & Liebmann (1973) , as previous work has shown that the herb and extracts are at least two or four times more active than one would expect from their THC content (Carlini et al., 1974; Fairbaim & Pickens, 1981) . The effect of aspirin on sedative action and its reversal by prostaglandin E2 (PGE2) has also been determined since previous work showed that the cataleptic effects of herb and extracts were antagonized by aspirin and restored by PGE2 (Fairbaim & Pickens, 1979; 1981) . In addition I have determined the sedative activity of cannabidiol (CBD). Finally, as cannabis tea made by infusing powdered herb with boiling water is also sedative in man, I have attempted to find the proportion of sedative action residing in the water soluble fraction, by testing an infusion made by pouring boiling water on cannabis herb. I have also tested an aqueous extract from a sample of herb from which the can-nabinoids were completely extracted by petroleumether.
Methods Preparation ofmaterialfor oral administration
A'-trans-Tetrahydrocannabinol and cannabidiol were suspended in 2.5% solution of Tween 80 as previously described (Fairbairn & Pickens, 1979) .
Cannabis Herbal cannabis was prepared by careful drying of plant material and then separation from the thick stems by rubbing or by sifting. The plants were grown from seed in our own experimental gardens and extracts were prepared from two varieties. One variety, UNC 335, was from a THC-rich plant and the other, UNC 354, was from a CBD-rich strain (Fairbairn & Liebmann, 1974) . All experiments were performed using non-decarboxylated powder. For administration, the powdered herb was suspended in mucilage of tragacanth B.P.
Ethanolic and petroleum-ether (40°o60°) extracts were prepared as described in a previous paper (Fairbairn & Pickens, 1981) .
Water extracts of 'whole' herb were prepared by adding 500 ml of boiling water to 100 g dried cannabis. The infusions were allowed to stand until cool and then filtered.
Water extracts of cannabinoid-free herb were prepared from both THC-rich and CBD-rich strains by percolating 50 g of finely powdered herb with petroleum-ether (40°60°) until all traces of cannabinoids had been removed, as described in our previous paper (Fairbairn & Pickens, 1981) . Hot water extracts were prepared by adding 500 ml of boiling water to 100 g of the cannabinoid-free dried marc, allowing to cool and filtering. Doses of filtrate were expressed in mg of 'whole' cannabis herb/kg. Some of the freshly prepared filtrates were tested in mice, the remainder was freeze-dried and stored at -20°C in the dark, and the re-dissolved powders were tested in mice for sedative activity. Cold water extracts were prepared by percolating cold chloroform-water through the petroleum-ether-exhausted Fairbairn & Liebmann (1973) . The (Fairbairn & Pickens, 1979; 1981 The dose-response relationships for herb and extracts were established for three or four dose levels using 7 mice per group. All calculations are based on cumulative moving means of the activity scores carried out on different days as described in a previous paper (Fairbairn & Pickens, 1981 
Prostaglandin inhibition
In these experiments all mice were pretreated with aspirin, 10 mg/kg orally, suspended in mucilage of tragacanth, followed 3 min later by the cataleptic compounds. The sedative effect was measured at to + 2 h. Further groups of mice were given 10 mg/kg aspirin orally at to min, cataleptic samples at to + 3 min, and intraperitoneal PGE2 (3.3 Ag/kg) at to + 100 min. The sedative effects were measured at to + 2 h as before.
Calculation ofsedative potency
This has been expressed in two ways: (a) the sedative dose fifty (SD50) which is the dose in mg/kg required for 50% reduction in activity scores for control mice and calculated with 95% confidence limits by Finney's probit analysis (Finney, 1964) , from the linear graph relating probit percentage sedation (ordinate scale) against log dose (abscissa scale). (b) Calculation of areas or SDA50 which is the dose in mg/kg required for 50% reduction in the area beneath the graph relating sedation (expressed as Y2%) on the ordinate scale against time to 6 h on the abscissa scale. The method of calculating Y2 is described in detail in an earlier paper (Fairbairn & Pickens, 1981) .
Biological/chemical ratios (B/C)
The B/C ratio for each sample is the THC equivalent by biological assay (B) divided by the THC content by chemical analysis (C) and also described in the earlier paper (Fairbaim & Pickens, 1981 Figure 1 shows that the activity of the controls does not vary within the test time period and Table 1 shows that the control scores do not differ between to and to + 6 h.
Evaluation of the bioassay estimation ofsedation
The activity of THC 3 mg/kg orally and an infusion made with boiling water from a THC-rich cannabis plant is illustrated in Figure 1 . In these experiments the initial readings probably represent exploratory activity by the mice when put into a new cage (Svensson & Thieme, 1969) . However, I have included all the readings in the estimates of sedation. Table 2 . There was no significant deviation from parallelism for the dose-response lines of THC, CBD, chlorpromazine, and herb and extracts and comparisons between them are therefore valid (Figure 2) .
Sedative activities
A'-trans-Tetrahydrocannabinol (THC) was adminstered orally in doses from 0.06 mg/kg to 3 mg/kg; doses above 3 mg/kg gave 100% effect and were not used in the calculations of potency. The onset of the sedation was rapid and low values for SD50 were obtained from to + 30 min to to + 6 h (Table 2) Table 2 ). The onset of sedation was rapid and the SD50 value at to + 30 min No of scores given in parentheses. Untreated control mice were tested at to (a); to + 2 h (b); 4) + 4 h (c) and 4) + 6 h (d). When cannabis herb was tested, control mice were given mucilage of tragacanth B.P. (experiment 8); when extracts were tested, control mice were given 2.5% w/v Tween 80, 0.2 ml/20 g, (experiment 9) and when aqueous extracts and infusions were tested control mice were given water by oral administration (experiment 10).
Expt. (Figure 1 and Table 2 ). The SDA50
value for potency over 6 h was 1.26 (1.22-1.80) mg/kg (Figure 3 ).
Herbal canabis when assayed against THC was 4.47 times more active than would be expected from its THC content (Table 2 ). Individual B/C ratios at to + 0.5, to + t, + 1, t( + 2, to + 4 and to + 6 h were respectively 0. 47, 0.48, 10.78, 1.93 and 20.06 . These results indicate that the THC equivalent by bioassay exceeds the THC content by chemical analysis (3.04%) at all times except possibly to + 0.5 h and t0 + I h.
Ethanolic and petroleum-ether extracts when assayed against THC were 5.26 (sample 5) and 4.39 (sample 6) times more active than would be expected from their THC content (Table 2) .
Water inJiusion of whole herb showed sedative activity when very large doses of infusion were given. Figure I (0) Water infusions of cannabinoid-free herb showed sedative activity up to to + 6 h; SDA50 values were 2200 mg/kg and 6400 mg/kg respectively for infusions from a THC-rich and CBD-rich herb.
Aqueous and ethanolic extracts of cannabinoid-free herb The aqueous and ethanolic extracts of the freeze-dried powders 28-84A and 28-84 B, prepared from cannabinoid-free herbs had-low sedative potencies; the ethanolic extracts were less active than the aqueous extracts and despite repeated experiments, eight in all, no sedative activity was found in the 70% ethanolic extracts.
Effect ofaspirin
Aspirin, a prostaglandin synthesis inhibitor, had no sedative effect in doses of 10 to 400 mg/kg but 10 mg/kg of aspirin reversed the sedative responses to 3 mg/kg of THC, 40 mg/kg of herb and 1000 mg/kg of residue 28-84 A (Table 3 ). The sedative effect of chlorpromazine was not inhibited by aspirin. Prosta- Dose (mg/kg) Figure 3 Relative overall sedative potencies of A'-trans-tetrahydrocannabinol (THC) (0), cannabidiol (CBD) (-), cannabis herb (A) and a petroleum-ether extract (o) from t0 to t0 + 6 h after oral administration at t0 to female, albino, Tuck No. 1 strain mice in the activity cage. Ordinate scale: probit Y2% where Y22 is calculated as described in Fairbairn & Pickens, 1981. Abscissa scale: log dose mg/ or ml/kg. Potency as SDA50 for THC = 1.06 (0.98-1.15) mg/kg; for CBD = 4.72 (4.22-5.27) mg/kg; for herb = 7.76 (7.37-8.17) mg/kg and for the petroleum-ether extract (0.43/0.38-0.48) ml/kg. The potency of the herb which contained 3.04% THC and no CBD is greater than would be expected with B/C = 4.47. The potency of the petroleum extract which contained 0.56 mg THC/ml was also greater than would be expected with B/C = 4.39. glandin E2 (3.3 ,ug/kg i.p.) restored the sedative responses to THC, cannabis herb and residue 28-84 A; however, this small dose of PGE2 had a sedative effect of its own (Table 3) .
Discussion
The biological assay Estimates of sedative potency have been calculated on the cumulative moving means of the sedative scores for ten control groups measured on different days between November 1979 and March 1980. Thus estimates of potency are based on much larger sample sizes than would have been possible if comparisons between THC as standard, and extracts, as test preparations, had been limited to data collected on the same day, or days. Additionally the cost of the assay and the number of mice is reduced as some of the preceding data are used in the estimate of potency. Table 1 shows that the standard error of the moving mean reduces as more results are added to previous data. Thus on day 1 the standard error of the mean Table 2 Potency, expressed as SD50 (the dose in mg/kg required to give 50% sedation at different-times after oral administration at t0 hours) and as SDA50 (the dose required to give a 50% effect over 6 h) of A'-trans-tetra- Fairbairn & Pickens (1981) suggested that the 'difference between days' in their cataleptic work was due to the small sample for a day's work compared to the standard deviation and the sedative results described in this paper suggest that this principle applies to the sedative data too. The argument is further strengthened by showing that the 354 scores from the 34 control experiments form part of a normal distribution.
Variationi ofrelative potencies with time
The peak sedative activities of THC, CBD, chlorpromazine, herb and extracts do not coincide so that potencies of these, relative one to another, will vary according to the time at which the readings are made; thus one overall figure for potency (SDA50) has been calculated which is the activity over the 6 h period by the 'area method' described previously (Fairbairn & Pickens, 1981) . The comparisons of sedative potency are valid as the overall dose-response relationships do not differ significantly from parallelism ( Figure 3 ).
Sedative potency of 'whole' extracts compared to A'-trans-tetrahydrocannabinol (THC)
The potency of the herb, ethanolic and petroleumether extracts of the herb with no CBD content, cannot be accounted for in terms of their THC content alone. The results agree with those from our cataleptic work with THC, herb and extracts (Fairbairn & Pickens, 1981) and with those of Carlini et al., ( 1974) (7) (7) (7)
(7) proportion of the sedative effects of whole herb and extracts.
Effect ofaspirin
In cataleptic experiments it was shown that the responses to THC, herb and extracts involved a PGE2 mechanism (Fairbairn & Pickens, 1979; 1981 
